IDO1 and neoplasm: In ovarian cancer, IDO1 has been related to disease progression (30), chemotherapy resistance (9) and impaired survival (9, 31), based on expression analysis of IDO1 by in situ hybridization and immunohistochemistry of tumor specimens (9, 30, 31).